CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 45 enrolled
Drug / intervention
Propranolol +2 moredrug
Likely dose
Propranolol 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00934947
NCT00934947Phase 2Completed

The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol

University of North Carolina, Chapel Hill·interventional·Posted Jul 8, 2009·Updated Nov 17, 2017

In Brief

A Phase 2 clinical trial evaluating Propranolol, Placebo, and 1 other intervention for Burns and Pain. Completed, enrolled 45 participants across 4 sites.

Detailed Summary

The purpose of this study is to investigate the ability of propranolol to decrease pain and improve recovery in burn patients with a common genotype.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBurns, Pain
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 8, 2009
Enrollment StartJul 1, 2009
Primary CompletionFeb 1, 2011
Study CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 17.0 years ago

Interventions

Propranololdrug

40 mg

Placebodrug

sugar pill

Propanololdrug

120 mg twice per day